ISSN: 2167-065X

Pharmacologie clinique et biopharmaceutique

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Advances in Drug Delivery Systems: Enhancing Therapeutic Efficacy and Patient Compliance

Robert Henry

Recent advancements in drug delivery systems have revolutionized the field of medicine, offering new ways to enhance therapeutic efficacy and improve patient compliance. These innovative approaches have overcome many of the limitations associated with traditional drug administration methods, such as oral pills or injections. One notable development is the utilization of nanotechnology in drug delivery systems. Nanoparticles, ranging from a few nanometers to hundreds of nanometers in size, can be engineered to encapsulate drugs and precisely target specific tissues or cells within the body. This targeted delivery allows for increased drug concentration at the site of action, reducing potential side effects and optimizing therapeutic outcomes. Furthermore, nanocarriers can protect drugs from degradation, ensuring their stability and controlled release over a prolonged period. Another significant advancement is the development of implantable devices and wearable technologies that can deliver drugs in a continuous, controlled manner.